BDSI settles patent litigation with generic giant Teva
October 12, 2017 at 14:10 PM EDT
Raleigh-based BioDelivery Sciences International (Nasdaq: BDSI) has reached a settlement agreement with generic manufacturing giant Teva Pharmaceuticals.